Total Payments
$2,661
2024 Payments
$2,078
Companies
21
Transactions
150
Medicare Patients
368
Medicare Billing
$16,746
Payment Breakdown by Category
Food & Beverage$2,629 (98.8%)
Education$32.27 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,629 | 149 | 98.8% |
| Education | $32.27 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Organogenesis Inc. | $885.80 | 15 | $0 (2024) |
| ABBVIE INC. | $439.15 | 34 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $233.03 | 10 | $0 (2024) |
| Novo Nordisk Inc | $216.58 | 21 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $176.13 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $154.22 | 25 | $0 (2024) |
| PFIZER INC. | $95.23 | 6 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $62.64 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $56.94 | 4 | $0 (2024) |
| Galt Pharmaceuticals, LLC | $55.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,078 | 131 | Organogenesis Inc. ($639.74) |
| 2023 | $553.33 | 17 | Organogenesis Inc. ($246.06) |
| 2022 | $18.08 | 1 | Lilly USA, LLC ($18.08) |
| 2021 | $12.25 | 1 | Merck Sharp & Dohme Corporation ($12.25) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Organogenesis Inc. | AFFINITY (Medical Supply) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: WOUND CARE | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: ANTIBIOTIC | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Organogenesis Inc. | APLIGRAF (Device) | Food and Beverage | In-kind items and services | $57.58 | General |
| Category: WOUND CARE | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 353 | 513 | $28,763 | $15,364 |
| 2022 | 1 | 15 | 15 | $3,285 | $1,382 |
Total Patients
368
Total Services
528
Medicare Billing
$16,746
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 56 | $8,819 | $5,108 | 57.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 61 | $7,124 | $3,733 | 52.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 42 | $4,200 | $2,492 | 59.3% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 13 | 13 | $1,950 | $1,817 | 93.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 24 | 24 | $1,008 | $383.48 | 38.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 37 | $1,368 | $361.39 | 26.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 23 | 23 | $920.00 | $232.60 | 25.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 18 | 18 | $810.00 | $214.82 | 26.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 13 | $260.00 | $210.60 | 81.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 24 | 24 | $840.00 | $208.22 | 24.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 24 | $240.00 | $201.60 | 84.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 26 | 26 | $546.00 | $195.15 | 35.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 12 | $252.00 | $114.24 | 45.3% |
| 82248 | Bilirubin level, direct | Office | 2023 | 14 | 14 | $168.00 | $68.88 | 41.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 11 | 44 | $176.00 | $15.70 | 8.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 82 | $82.00 | $8.11 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $3,285 | $1,382 | 42.1% |
About Dr. Michael Holland, DO
Dr. Michael Holland, DO is a Family Medicine healthcare provider based in Saraland, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2020. The National Provider Identifier (NPI) number assigned to this provider is 1932737491.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Holland, DO has received a total of $2,661 in payments from pharmaceutical and medical device companies, with $2,078 received in 2024. These payments were reported across 150 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,629).
As a Medicare-enrolled provider, Holland has provided services to 368 Medicare beneficiaries, totaling 528 services with total Medicare billing of $16,746. Data is available for 2 years (2022–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties General Practice, Family Medicine
- Location Saraland, AL
- Active Since 03/31/2020
- Last Updated 06/28/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1932737491
Products in Payments
- REXULTI (Drug) $236.54
- VRAYLAR (Drug) $208.86
- XIFAXAN (Drug) $176.13
- QULIPTA (Drug) $151.51
- Affinity (Medical Supply) $123.03
- Puraply (Medical Supply) $123.03
- LEQVIO (Drug) $117.78
- AFFINITY (Medical Supply) $112.63
- Ozempic (Drug) $103.61
- Wegovy (Drug) $86.19
- CYGNUS DUAL (Medical Supply) $84.46
- UBRELVY (Drug) $78.78
- VOQUEZNA (Drug) $62.64
- APLIGRAF (Device) $57.58
- Kerendia (Drug) $56.94
- Orphengesic Forte (Drug) $55.00
- Auvelity (Drug) $43.54
- ENTRESTO (Drug) $36.44
- NURTEC ODT (Drug) $35.17
- BREZTRI (Drug) $31.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Saraland
Jason West, M.d, M.D
Family Medicine — Payments: $19,004
Family Medicine $19,004
Howard Rubenstein, M.d, M.D
Family Medicine — Payments: $12,293
Family Medicine $12,293
Richard Valentine, Md, MD
Family Medicine — Payments: $9,235
Family Medicine $9,235
Bryan Crenshaw, Md, MD
Family Medicine — Payments: $6,873
Family Medicine $6,873
Mark Mcdaniel, Md, MD
Family Medicine — Payments: $6,448
Family Medicine $6,448
Scott Carver
Family Medicine — Payments: $5,741
Family Medicine $5,741